SEC Form 4 · accession 0001437749-17-019679
Perspective Therapeutics, Inc. · CATX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Krachon
Officer — VP of Sales & Marketing
Period of report
Nov 20, 2017
Accepted (ET)
Nov 21, 2017 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000728387
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 20, 2017 | P | 19,609 | $0.50 | A | 19,609 | D | |
| Common Stock | Nov 20, 2017 | P | 6,965 | $0.50 | A | 26,574 | D | |
| Common Stock | Nov 20, 2017 | P | 10,600 | $0.50 | A | 37,174 | D | |
| Common Stock | Nov 20, 2017 | P | 700 | $0.50 | A | 37,874 | D | |
| Common Stock | Nov 20, 2017 | P | 1,400 | $0.50 | A | 39,274 | D | |
| Common Stock | Nov 20, 2017 | P | 126 | $0.47 | A | 39,400 | D | |
| Common Stock | Nov 20, 2017 | P | 500 | $0.47 | A | 39,900 | D | |
| Common Stock | Nov 20, 2017 | P | 200 | $0.46 | A | 40,100 | D | |
| Common Stock | Nov 20, 2017 | P | 10,160 | $0.50 | A | 50,260 | D | |
| Common Stock | Nov 20, 2017 | P | 300 | $0.47 | A | 50,560 | D | |
| Common Stock | Nov 20, 2017 | P | 40 | $0.49 | A | 50,600 | D | |
| Common Stock | Nov 20, 2017 | P | 200 | $0.48 | A | 50,800 | D | |
| Common Stock | Nov 20, 2017 | P | 200 | $0.47 | A | 51,000 | D | |
| Common Stock | Nov 20, 2017 | P | 100 | $0.48 | A | 51,100 | D | |
| Common Stock | Nov 20, 2017 | P | 3,900 | $0.48 | A | 55,000 | D |
Table II — derivative securities
No Table II lines on this filing.